PEBP1 and pancreatic neoplasm: In contrast, RIPK4 facilitated pancreatic cancer cell migration and invasion via the phosphatidylethanolamine binding protein 1 (PEBP1) degradation-induced activation of the RAF1/MEK/ERK pathway (Qi et al., 2018).